Veroplex® Proprietary Vero Cell Platform

Need an established and validated platform to manufacture your vaccine candidate? Look no further than Ology Bio’s proprietary Veroplex Platform, comprised of proven Vero cells, patented processes for vaccine development and production, and experienced regulatory support.

• Reliable, stable, and proven high-yield working cell banks (WCBs)
• WCB passage number as low as 133
• Adapted to grow in serum-free media, and for growth on 60-250 micron microcarriers
• Consistent density, viability, and production during scale-up from 15 L to 6,000 L bioreactors
• Extensive regulatory documentation and expert support, DMF 10336
• Accepted by regulatory authorities in more than 60 countries